Host Genes Critical for Flavivirus Infection
对黄病毒感染至关重要的宿主基因
基本信息
- 批准号:10293600
- 负责人:
- 金额:$ 39.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-11-14 至 2023-10-31
- 项目状态:已结题
- 来源:
- 关键词:Antiviral AgentsAntiviral TherapyBindingBinding ProteinsBiochemical GeneticsCell physiologyCellsCellular biologyComplexCongenital AbnormalityCulicidaeDataDengueDengue InfectionDengue VirusDependenceDiseaseDisease OutbreaksDistantEndoplasmic ReticulumFlaviviridaeFlavivirusFlavivirus InfectionsGenesGenetic ScreeningGoalsHepatitis C virusHumanImmunoprecipitationIndividualInfectionIntegration Host FactorsLife Cycle StagesLinkMedicalMembraneMessenger RNAMethodsMolecularMultiprotein ComplexesNonstructural ProteinPharmacologyPlayProcessProtein Binding DomainProtein IsoformsProtein-Protein Interaction MapProteinsPublic HealthRNARNA VirusesRNA replicationRNA-Binding ProteinsRibosomesRoleTestingTherapeuticTranslationsUntranslated RNAViralViral ProteinsVirusVirus DiseasesVirus ReplicationWidespread DiseaseZIKAZika Virusbasecrosslinkgenetic approachgenome-wideglycosylationhuman diseaseinnovationinsightmembermosquito-borneprotein complexrecruittherapeutic targetunborn childviral RNA
项目摘要
PROJECT SUMMARY
The mosquito-borne flaviviruses have (re-)emerged causing widespread disease with dengue virus and Zika
virus as important members. In recent Zika virus outbreaks, it became clear that the virus can cause severe
congenital abnormalities in unborn children, posing an immediate threat to public health. Like other positive-
stranded RNA viruses, flaviviruses extensively rearrange endoplasmic reticulum (ER) membranes to create a
favorable niche for RNA replication. The ER-membrane serves as physical support for the coordinated
accumulation of viral and cellular components required for efficient replication. However, little is known about
the molecular mechanisms by which viral proteins assemble functional RNA replication complexes and, more
specifically, the role of host proteins in this process. Through genome-scale genetic screens, we have
discovered that ER-membrane multiprotein complexes, including the oligosaccharyltransferase complex
(OST), have critical roles in flavivirus infection. We pinpointed the role of the OST complex to viral RNA
replication but unexpectedly found that the enzymatic activity of OST in N-linked glycosylation is dispensable.
We demonstrated that the OST complex binds to several nonstructural proteins and is present in complexes
associated with viral RNA. Our preliminary data suggest that flaviviruses have evolved to coordinate the
assembly of functional RNA replication complexes at the ER membrane through specific interactions between
the host proteins and viral proteins/RNA. Two integrated specific aims are proposed to understand the
mechanisms by which flaviviruses exploit host factors to establish productive infection. In aim 1, we will use
biochemical and genetic approaches to precisely map the protein-protein interactions between individual viral
proteins and the cellular factors with a focus on the OST complex. Given the strong dependence on the OST
complex, these interaction interfaces may serve as a basis for pharmacological disruption. In aim 2, we will
take an RNA-centric approach to systematically uncover cellular proteins that form viral RNA-protein
complexes in dengue and Zika infected cells. We will use innovative methods including ChIRP-MS and CLIP-
seq, that will provide a detailed and comprehensive overview of the proteins, and even the individual protein
domains that bind to the viral RNA. These studies will fundamentally advance our understanding of the
molecular mechanisms by which different flaviviruses have subverted ER functions to promote their infectious
cycles, and may help to develop therapeutic targets for host-based antivirals.
项目摘要
蚊子传播的黄病毒已经(重新)出现,导致登革热病毒和寨卡病毒的广泛传播
病毒作为重要成员。在最近的寨卡病毒疫情中,很明显,该病毒可导致严重的
胎儿先天畸形,对公共卫生构成直接威胁。像其他积极的-
黄病毒广泛地重排内质网(ER)膜,以产生一种
有利于RNA复制的生态位。ER膜作为协调的细胞的物理支持,
有效复制所需的病毒和细胞成分的积累。然而,人们对
病毒蛋白组装功能性RNA复制复合物的分子机制,以及更多
特别是宿主蛋白在这一过程中的作用。通过基因组规模的遗传筛选,
发现ER-膜多蛋白复合物,包括寡糖基转移酶复合物,
(OST),在黄病毒感染中起关键作用。我们确定了OST复合物对病毒RNA的作用,
复制,但出乎意料地发现OST在N-连接糖基化中的酶活性降低。
我们证明了OST复合物与几种非结构蛋白结合,并以复合物的形式存在
与病毒RNA有关。我们的初步数据表明,黄病毒已经进化到协调
在内质网膜上通过特异性相互作用组装功能性RNA复制复合物,
宿主蛋白和病毒蛋白/RNA。提出了两个综合的具体目标,以了解
黄病毒利用宿主因子建立生产性感染的机制。在目标1中,我们将使用
生物化学和遗传学方法来精确绘制单个病毒之间的蛋白质-蛋白质相互作用,
蛋白质和细胞因子,重点是OST复合物。鉴于对OST的强烈依赖
复杂,这些相互作用界面可以作为药理学破坏的基础。在目标2中,我们
采用以RNA为中心方法系统地揭示形成病毒RNA蛋白的细胞蛋白
登革热和寨卡病毒感染的细胞中的复合物。我们将使用创新的方法,包括ChIRP-MS和CLIP-
seq,这将提供一个详细和全面的概述蛋白质,甚至个别蛋白质
与病毒RNA结合的结构域。这些研究将从根本上推进我们对
不同黄病毒破坏ER功能以促进其感染性的分子机制
周期,并可能有助于开发基于宿主的抗病毒药物的治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jan E Carette其他文献
Jan E Carette的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jan E Carette', 18)}}的其他基金
Human 3D neuro-muscular assembloids to study cell tropism and host factor utilization of divergent neuropathogenic enteroviruses
人类 3D 神经肌肉组合体用于研究不同神经致病性肠道病毒的细胞向性和宿主因子利用
- 批准号:
10450520 - 财政年份:2022
- 资助金额:
$ 39.13万 - 项目类别:
Human 3D neuro-muscular assembloids to study cell tropism and host factor utilization of divergent neuropathogenic enteroviruses
人类 3D 神经肌肉组合体用于研究不同神经致病性肠道病毒的细胞向性和宿主因子利用
- 批准号:
10595022 - 财政年份:2022
- 资助金额:
$ 39.13万 - 项目类别:
Host determinants of enterovirus RNA replication and in vivo neuropathogenesis
肠道病毒RNA复制和体内神经发病机制的宿主决定因素
- 批准号:
10379389 - 财政年份:2021
- 资助金额:
$ 39.13万 - 项目类别:
Host determinants of enterovirus RNA replication and in vivo neuropathogenesis
肠道病毒RNA复制和体内神经发病机制的宿主决定因素
- 批准号:
10209690 - 财政年份:2021
- 资助金额:
$ 39.13万 - 项目类别:
Host determinants of enterovirus RNA replication and in vivo neuropathogenesis
肠道病毒RNA复制和体内神经发病机制的宿主决定因素
- 批准号:
10598484 - 财政年份:2021
- 资助金额:
$ 39.13万 - 项目类别:
Deciphering the inositol phosphate code in viral pathogenesis and immunity
破译病毒发病机制和免疫中的肌醇磷酸密码
- 批准号:
10265715 - 财政年份:2020
- 资助金额:
$ 39.13万 - 项目类别:
Deciphering the inositol phosphate code in viral pathogenesis and immunity
破译病毒发病机制和免疫中的肌醇磷酸密码
- 批准号:
10397756 - 财政年份:2020
- 资助金额:
$ 39.13万 - 项目类别:
Deciphering the inositol phosphate code in viral pathogenesis and immunity
破译病毒发病机制和免疫中的肌醇磷酸密码
- 批准号:
10557840 - 财政年份:2019
- 资助金额:
$ 39.13万 - 项目类别:
Deciphering the inositol phosphate code in viral pathogenesis and immunity
破译病毒发病机制和免疫中的肌醇磷酸密码
- 批准号:
10338053 - 财政年份:2019
- 资助金额:
$ 39.13万 - 项目类别:
Host Genes Critical for Flavivirus Infection
对黄病毒感染至关重要的宿主基因
- 批准号:
10054984 - 财政年份:2018
- 资助金额:
$ 39.13万 - 项目类别:
相似海外基金
Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children
用于儿童抗病毒治疗的剂量灵活组合 3D 打印输送系统
- 批准号:
10682185 - 财政年份:2023
- 资助金额:
$ 39.13万 - 项目类别:
COVID-19 Immunologic Antiviral therapy with Omalizumab (CIAO trial) - An Adaptive Phase II Randomized-Controlled Clinical Trial
使用奥马珠单抗进行 COVID-19 免疫抗病毒治疗(CIAO 试验)——适应性 II 期随机对照临床试验
- 批准号:
475843 - 财政年份:2022
- 资助金额:
$ 39.13万 - 项目类别:
Studentship Programs
COVID-19 Immunologic Antiviral therapy with Omalizumab (CIAO trial) - An Adaptive Phase II Randomized-Controlled Clinical Trial
使用奥马珠单抗进行 COVID-19 免疫抗病毒治疗(CIAO 试验)——适应性 II 期随机对照临床试验
- 批准号:
474485 - 财政年份:2022
- 资助金额:
$ 39.13万 - 项目类别:
Studentship Programs
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
用于抗病毒治疗的布尼亚病毒核酸内切酶抑制剂的发现
- 批准号:
10683329 - 财政年份:2022
- 资助金额:
$ 39.13万 - 项目类别:
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
用于抗病毒治疗的布尼亚病毒核酸内切酶抑制剂的发现
- 批准号:
10481430 - 财政年份:2022
- 资助金额:
$ 39.13万 - 项目类别:
An interdisciplinary approach towards antiviral therapy discovery
抗病毒疗法发现的跨学科方法
- 批准号:
nhmrc : 1196520 - 财政年份:2021
- 资助金额:
$ 39.13万 - 项目类别:
Investigator Grants
Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapy
应用“组学”方法预测退伍军人在使用直接作用抗病毒疗法治愈 HCV 后的肝失代偿事件和肝细胞癌
- 批准号:
10260234 - 财政年份:2021
- 资助金额:
$ 39.13万 - 项目类别:
Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapy
应用“组学”方法预测退伍军人在使用直接作用抗病毒疗法治愈 HCV 后的肝失代偿事件和肝细胞癌
- 批准号:
10548114 - 财政年份:2021
- 资助金额:
$ 39.13万 - 项目类别:
Disparities in the Diffusion of Direct-Acting Antiviral Therapy for Hepatitis C among Baby Boomers: A Mixed-Methods Study
婴儿潮一代丙型肝炎直接作用抗病毒疗法传播的差异:一项混合方法研究
- 批准号:
10400318 - 财政年份:2020
- 资助金额:
$ 39.13万 - 项目类别:
COVID-19 Immunologic Antiviral therapy with Omalizumab (CIAO trial)
使用奥马珠单抗进行 COVID-19 免疫抗病毒治疗(CIAO 试验)
- 批准号:
449805 - 财政年份:2020
- 资助金额:
$ 39.13万 - 项目类别:
Studentship Programs














{{item.name}}会员




